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Abstract.  The mouse anterior pituitary tumor cell 
line,  AtT-20,  targets secretory proteins into two distinct 
intracellular pathways. When the DNA that encodes 
trypsinogen is introduced into AtT-20 cells, the protein 
is sorted into the regulated secretory pathway as 
efficiently as the endogenous peptide hormone ACq'H. 
In this study we have used double-label immunoelec- 
tron microscopy to demonstrate that trypsinogen 
colocalizes in the same secretory granules as ACTH. 
In vitro mutagenesis was used to test whether the in- 
formation for targeting trypsinogen m  the secretory 
granules resides at the amino (NH2) terminus of the 
protein.  Mutations were made in the DNA that en- 
codes trypsinogen,  and the mutant proteins were 
expressed in AtT-20 cells to determine whether intra- 
cellular targeting could be altered.  Replacing the tryp- 
sinogen signal peptide with that of the kappa-immu- 
noglobulin light chain,  a constitutively secreted 
protein, does not alter targeting to the regulated secre- 
tory pathway.  In addition,  deletion of the NH2-terminal 
"pro" sequence of trypsinogen has virtually no effect 
on protein targeting.  However, this deletion does affect 
the signal peptidase cleavage site, and as a result the 
enzymatic activity of the truncated trypsin protein is 
abolished. We conclude that neither the signal peptide 
nor the 12 NH2-terminal amino acids of trypsinogen 
are essential for sorting to the regulated secretory 
pathway of AtT-20 cells. 
T 
HE intracellular  route taken by secretory proteins in 
eukaryotic cells, from the endoplasrnic reticulum (ER) 1 
through the Golgi apparatus  and to the cell surface,  is 
well established (56). Classical secretory cells, such as those 
of exocrine or endocrine tissues, synthesize, concentrate, and 
then store one or a few secretory products in large, electron- 
dense, membrane-bound vesicles called secretory granules. 
Secretion from these specialized  secretory cells is triggered 
by an external signal,  and thus has been termed "regulated" 
secretion (67).  Other ceils that  lack specialized  secretory 
granules  secrete proteins in an unregulated  or constitutive 
manner.  It is generally believed that constitutively  secreted 
proteins traverse the secretory pathway from the ER m the 
Golgi complex and then are shuttled to the cell surface via 
small carrier vesicles.  No extracellular  signal is required m 
trigger  exocytosis of constitutive  vesicles. 
The mouse anterior pituitary tumor cell line, AtT-20, be- 
haves as a regulated  secretory cell in culture.  The endoge- 
nous prohormone proopiomelanocortin (POMC) is synthe- 
sized, glycosylated, and proteolytically processed to mature 
products including  adrenocorticotropic hormone (ACTH). 
ACTH is concentrated in dense-core secretory granules,  and 
its release is stimulated  by secretagogues  (47, 48). In addi- 
1. Abbreviaaons used in this  paper: ER, endoplasmic reticulum; Ksp, kappa 
signal peptide;  LTR, long terminal repeat; POMC,  proopiomelanocortin; 
RSV, Rous sarcoma virus; TG, truncated G (protein). 
tion, some proteins reach the cell surface of Afr-20 cells via 
the constitutive  secretory route.  Both an endogenous retro- 
viral membrane glycoprotein, gpT0 (31), and the secreted ex- 
tracellular matrix protein, laminin (8), are transported exclu- 
sively via the constitutive secretory pathway. The mechanism 
of these intracellular  targeting  processes is at present un- 
known, but it may involve recognition of specific sorting sig- 
nals in the secreted proteins themselves (5). 
Protein  targeting  to  the  regulated  secretory pathway  is 
apparently  conserved among  endocrine hormones.  When 
human proinsulin  (54) or human growth hormone (52) are 
stably expressed in AtT-20 cells via DNA-mediated transfec- 
tion, they are sorted into the regulated secretory pathway at 
least as well as the endogenous hormone  POMC/ACTH. 
Furthermore, we have recently shown that the exocrine pro- 
tein, rat anionic  trypsinogen, is also selectively targeted  to 
the regulated  secretory pathway in the endocrine cell line 
AtT-20 (8).  Similar  evidence has been obtained for human 
proparathyroid hormone expressed and secreted by a rat pi- 
tuitary cell line, GH4 (37), and for human proenkephalin  ex- 
pressed by AtT-20 cells (12). Thus proteins from different 
species as well as endocrine and exocrine tissues share the 
ability m be recognized and targeted to the regulated  secre- 
tory pathway in AtT-20 cells. 
A general approach to elucidating the mechanism of intra- 
cellular protein targeting  is the use of recombinant DNA 
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cDNA is modified in vitro and, subsequently, the mutated 
protein is expressed either in vitro or in vivo to address 
whether a targeting signal has been disrupted. We have taken 
this approach to attempt to localize the signal responsible for 
targeting to the regulated secretory pathway.  The exocrine 
protein, trypsinogen, was chosen for this study for several 
reasons. Inasmuch as the three-dimensional structure of  both 
trypsinogen (22,  45)  and trypsin (39,  65)  are known, the 
structural information can be used to design mutations that 
will involve the surface of the protein (where signal recogni- 
tion is likely to occur), and that are not likely to drastically 
alter the overall folding or enzymatic activity of the mole- 
cule. If  proteins do not fold correctly, their ability to be trans- 
ported beyond the ER is severely compromised (13, 26, 46, 
66).  In addition, because trypsinogen can be converted to 
trypsin, the proteolytic activity of the secreted mutant pro- 
tein can be assayed as a very sensitive measure of correct 
protein folding. If targeting is disrupted but enzymatic activ- 
ity is maintained, it is more likely that the mutation has al- 
tered a targeting signal, and not simply changed the overall 
structure of the protein, making the signal unrecognizable or 
inaccessible (58,  69). 
Many intracellular targeting signals are known to be pres- 
ent at the NH2 terminus of the targeted proteins. For exam- 
ple, mitochondrial proteins (20, 36, 38, 40); chloroplast pro- 
teins (59, 62, 70),  some nuclear proteins (17, 19, 33, 55, 61, 
74), and some proteins targeted to the ER have NH2-terminal 
transport signals. Most recently, the yeast vacuolar targeting 
signal of procarboxypeptidase Y has been shown to reside in 
the NH2-terminal propeptide (42,  68).  In this report data 
are presented that demonstrate the neither the signal peptide 
nor the NH2-terminal "pro" peptide of trypsinogen are es- 
sential for targeting to the regulated secretory pathway in 
AtT-20 cells; the intracellular targeting information is appar- 
ently not present at the amino terminus of this regulated 
secretory protein. 
Materials and Methods 
Materials 
The M13 sequencing primer, synthetic DNA linkers, restriction endonu- 
cleases, and "I"4 ligase were from New England Biolabs (Beverly,  MA). T4 
polynucleotide kinase was from Pharmacia Fine Chemicals (Piscataway, 
NJ). The Klenow fragment of DNA polymerase I was generously provided 
by  P.  Walter's  Laboratory  at  University  of California,  San  Francisco 
(UCSF). [35S]cysteine was from Amersham Corp. (Arlington Heights, IL). 
Rabbit  anti-trypsinogen antibodies  and  the  trypsinogen standard  were 
kindly provided by Corey Largman (Veterans Administration Medical Cen- 
ter, Martinez, CA). Mutagenic oligonucleotides were synthesized on an Ap- 
plied Biosystems (Foster City, CA) model 380B  DNA synthesizer by the 
Biomolecular Resource Center (UCSF).  Bovine trypsin and 8-Br-cAMP 
were from Sigma Chemical Co. (St. Louis, MO). Nitrocellulose for West- 
ern blots was from Sartorius Filters (Hayward, CA) and for colony and 
phage screening was from Schleicher & Schuell, Inc. (Keene, NH). Gold 
conjugated to goat anti-rabbit antibody was from Janssen Pharmaceutica 
(Piscataway,  N.J.). 
Cell Culture and Transfections 
AtT-20/D-16 cells were grown in Dulbecco's modified Eagle's medium H-21, 
supplemented with 10% fetal calf serum and penicillin/streptomycin, under 
a  15%  CO2 atmosphere at 37°C. Transfections of AtT-20  cells were by a 
calcium phosphate precipitation protocol described p~viously (8, 54). Co- 
transfections with the selectable plasmid pSV2neo (63) and the nonselecta- 
ble plasmids coding for the trypsinogen proteins described in the text were 
performed using 20 ~tg of pSV2neo and  100 ~tg of nonselectable plasmid 
per 3  x  106 AtT-20 cells. Selection was with 0.25 rng/ml G418 (active drug 
concentration) (Gibeo Laboratories,  Grand  Island,  NY)  for 2  wk after 
which time individual clones were isolated with cloning rings. Clones were 
expanded in media containing 0.125 mg/ml G418 and expressing clones were 
identified using a Western blot assay described previously (8,  10). 
Quantitative Secretion Assay: Calculation of  the 
Sorting Index 
A complete description and derivation of this assay is presented by Moore 
and Kelly (52). Briefly,  ART-20 cells were metabolically labeled for >-16 h 
with [35S]cysteine to approach a steady-state labeled condition. The cells 
were then incubated in normal medium to chase the labeled, constitutively 
secreted proteins out of the cell. After two 3-h chases, the cells were treated 
for 3 h with the secretagogue 8-Br-cAMP (5 mM) to stimulate the rate of 
secretion from the regulated pathway.  Wild-type and mutant trypsinogen 
proteins were immunoprecipitated and analyzed by sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis  (SDS-PAGE) (8). The amount of  labeled 
trypsinogen in various samples was quantified by scanning the autoradio- 
grams with an LKB soft laser densitometer (LKB Instruments, Inc., Gaith- 
ersburg, MD) or by solubilizing gel slices and counting directly (72).  The 
immunoprecipitations were quantitative and 80-100 % of the initial radioac- 
tivity was recovered in all experiments presented here. The sorting index 
is the ratio of the increased rate of secretion when the cells are stimulated 
with 8-Br-cAMP to the steady-state rate of  release in the absence of stimula- 
tion. As discussed previously (52), the sorting index is proportional to the 
probability a nascent protein enters the regulated pathway divided by the 
probability that it enters the constitutive pathway. 
DNA Constructions and In Vitro Mutagenesis 
Standard recombinant DNA techniques were used for the following plasmid 
constructions (48). 
pRSV.':Trypsinogen. To achieve higher trypsinogen expression in AtT-20 
cells, the trypsinogen-coding region from pSV2neo: :MTp-trypsinogen was 
subcloned 3' to the Rous sarcoma virus (RSV) long terminal repeat (LTR) 
(28). pRSV-truncated G (TG) (52) was digested with Bgl ll; the Bgl II site 
was filled in using the Klenow fragment of DNA polymerase i and convened 
to a Hind III site with a synthetic Hind III linker. The TG gene was then 
completely removed by digestion with Hind HI; the resulting vector DNA 
now contained a unique Hind III site just downstream of the RSV LTR. The 
complete pretrypsinogen DNA was isolated as a Barn HI-Sal I restriction 
fragment from pSV2neo: :MTp-trypsinogen (8). The ends of this DNA frag- 
ment were also converted to Hind III sites by the use of synthetic Hind III 
linkers. (The Barn HI site was maintained and was later used in constructing 
the pRSV: :Ksp-trypsinogen vector.) The trypsinogen fragment was ligated 
into the RSV LTR vector DNA to obtain the desired pRSV::trypsinogen 
plasmid. After transformation of Escherichia coli strain DH1  (34), clones 
harboring plasmids with the desired insert in the correct orientation were 
identified by restriction mapping. 
pRSV.':Ksp Ikypsinogen.  Three separate DNA  fragments were engi- 
neered to create an expression vector coding for trypsinogen with the kappa 
signal peptide. First, the DNA encoding the MPCU kappa signal peptide 
(Ksp) was isolated as a Bam HI-Hinc II restriction fragment (43). The origi- 
nal Pvu II site upstream of the initiating methionine of the Ksp was con- 
verted to a Bam HI site in a previous subcloning construction (Matsuuchi 
and Kelly, manuscript submitted for publication). HinclI cleaves just two 
amino acids before the end of the signal peptide leaving a blunt end. This 
blunt end was converted to a Hind HI site using a synthetic linker to allow 
the use of a convenient Hind IH site in trypsinogen. Second, the trypsino- 
gen-coding sequence was isolated as a Hind llI-Sst I fragment from pTRAP 
(29).  This DNA fragment contains the entire trypsinogen sequence, but 
lacks the signal peptide. Ligation of the Ksp Bam HI-Hind III fragment to 
the trypsinogen Hind III-Sst I  fragment creates an in-frame junction be- 
tween the Ksp and trypsinogen sequences. The Hind III linker contributes 
six nucleotides that maintain the length of the Ksp, but alters the sequence 
from Asp and Gly to Gin and Ala. Third, the RSV vector was prepared by 
partially digesting pRSV: :trypsinogen with Barn HI and a complete diges- 
tion with Sst I. The Bam HI-Sst I vector fragment cleaved at the Bam HI 
site immediately after the RSV LTR was isolated by agarose gel electropho- 
resis. The three DNA fragments were then ligated (Ksp, Bam HI-Hind III; 
trypsinogen, Hind llI-Sst I; pRSV, Bam HI-Sst I). The plasmid pRSV: :Ksp 
trypsinogen was isolated and identified by restriction mapping. The DNA 
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confirmed using a double-stranded DNA-sequencing protocol (11). 
pRSV.':Apro trypsin was constructed using a double-primer oligonucleo- 
tide mutagenesis protocol (75).  The intronless trypsinogen minigene was 
subcloned into M13mp8 as described (15). This single-stranded antisense 
clone was used as the template for mutagenesis. A 24-nucleotide-long muta- 
genie primer, TB04, (TB04 =  5'~ATCG-'IqW_JCtA~, 
was synthesized  by the Biomolecular Resource Center at UCSE TB04 spans 
the desired 24-nucleotide deletion, which when incorporated will lead to 
the deletion of the 8-amino acid "pro" sequence. Both the mutagenic oligonu- 
cleotide TBIM and the M13  sequencing primer (5'GTAAAACGACGC_~- 
CAGT3') were annealed to the single-stranded antisense trypsinogen M13 
template DNA. After extension with the Klenow fragment of DNA poly- 
merase I and ligation with T4 DNA ligase, E. coli strain JM101 was trans- 
formed with the DNA. The resulting phage plaques were screened using 
32p end-labeled TB04 (14). 14% of the plaques hybridized to the TB04 oli- 
gonucleotide and 4/4 were shown by DNA sequencing to contain the desired 
Apro trypsin mutation. Double-stranded phage DNA was isolated and the 
372-bp Hind III-Xho I restriction fragment containing the Apro trypsin mu- 
tation was used to replace the corresponding wild-type restriction fragment 
in pRSV: :trypsinogen to create pRSV::Apro trypsin. The DNA sequence 
of the deletion mutation in the expression plasmid was confirmed using a 
double-stranded supercoiled DNA sequencing protocol (11). 
pRSE':Apro D--N trypsin was constructed by isolating the Eco RI-Xho 
! restriction fragment containing the Asp---Asn 102 (D--,-N102) active site 
mutant from pTRAP D~N102 (29). This fragment was used to replace the 
wild-type fragment in pRSV::Apro trypsin using standard subcloning pro- 
tocols  (49).  The  D~N102  mutation  was  confirmed by  sequencing the 
double-stranded plasmid DNA of pRSV::AproD-"N trypsin (11). 
Protein Sequence Analysis 
Apro trypsin-expressing cells were labeled overnight with  [3SS]cysteine 
and Apro trypsin was purified from both the medium and cell extract by 
immunoprecipitation. The radiolabeled Apro trypsin was further purified 
and concentrated by SDS-PAGE (9, 32). The final pellets were dissolved in 
200 I~1 of 0.1% SDS, 0.1 mM EDTA, 0.05 M Tris, pH 7.9, 5 mM DTT, and 
0.15 M Natl. The media sample contained ~100,000 cpm and the cell ex- 
tract sample m30,000 cpm. The sequence analysis was performed on an Ap- 
plied Biosystems gas-phase sequencer, model 470A,  by the Biomolecular 
Resource Center at UCSE Anilinothiazolinone amino acids were collected 
at each cycle and [asS] counts per minute were determined. 
lmraunoelectron Microscopy 
RSV-Tryp cells were removed from their culture dishes using EGTA (5 mM) 
in PBS. The cells were pelleted in BEEM capsules (Polysciences, Inc., War- 
rington, PA) by centrifugation at 1,000 rpm for 5 min. The supernatant was 
removed, and the cell pellet was immediately immersed in a fixation solu- 
tion containing 4% paraformaldehyde, 0.1% glutaraldehyde, 0.1 M cacodyl- 
ate buffer (pH 7.4),  4%  sucrose, and 15% picric acid (18). After fixation 
the cells were embedded in Lowicryl K4M (Polysciences, Inc.) essentially 
as described (68). 
The Lowicryl-embedded cells were sectioned, collected on nickel grids, 
and processed as described (2). The first side of the section was incubated 
with rabbit anti-ACTH antibodies followed by goat anti-rabbit antibodies 
coupled to 20-rim gold. This side was then coated with Formvar as described 
(18) before the second side of the section was incubated with rabbit anti- 
trypsinogen antibodies followed by goat anti-rabbit antibodies coupled to 
5-nm gold. After the antibody incubations, the grids were stained with 2% 
aqueous osmium tetraoxide for 10 min, and then with 2% aqueous uranyl 
acetate for 5 rain. Finally the grids were examined in a JEOL 100B electron 
microscope (JEOL USA, Peabody, MA). 
Results 
Trypsinogen Colocalizes With ACTH in Dense-Core 
Secretory Granules of  AtT-20 Cells 
We have previously shown that the exocrine protein rat an- 
ionic trypsinogen is targeted to dense-core secretory gran- 
ules in the endocrine cell line AtT-20 (8). Cell fractionation 
as well as secretagogue-stimulated release showed that tryp- 
sinogen behaves similarly to the endogenous regulated secre- 
tory  protein  POMC/ACTH.  To  demonstrate  directly  that 
trypsinogen is present in the same secretory granule as ACTH, 
and is not exported through  a parallel regulated secretion 
pathway, we carried out a double-label immunoelectron mi- 
croscopy experiment. 
A human metaUothionein promoter was initially employed 
to control the expression of trypsinogen in AtT-20 cells (8). 
However,  the resulting cell line (Tryp-7) expressed insuffi- 
cient levels of trypsinogen to detect by immunoelectron mi- 
croscopy. Therefore an expression vector was constructed 
with the strong promoter-enhancer element, the Rous sar- 
coma virus (RSV)  long terminal repeat (LTR), controlling 
the expression of trypsinogen. The trypsinogen gene/cDNA 
(8, 15) was subcloned into pRSV-TG (52) (see Materials and 
Methods for details) to create pRSV: :trypsinogen. AtT-20 
cells were co-transfected with this DNA and pSV2neo as de- 
scribed previously (8). Clones expressing very high levels of 
trypsinogen were identified by a Western blot assay, and one, 
RSV-Tryp,  was  chosen for all  further  studies.  Using  the 
quantitative secretion assay described previously (52,  also 
see Materials and Methods), we determined that the tryp- 
sinogen made and secreted by RSV-Tryp cells was targeted 
to the regulated secretion pathway with the same efficiency 
as the trypsinogen expressed from the metallothionein pro- 
Table L Quantitative Comparison of  Protein Targeting to the Regulated Secretion Pathway in AtT-20 Cells 
DNA construction  Secreted  protein  Sorting  index* 
A. Regulated and constitutive secretory proteins 
-  POMC/ACTH  0.16  +  0.01  (2)* 
pSV2-neo::MTp trypsinogen  Trypsinogen  0.15  (1) 
pRSV::trypsinogen  Trypsinogen  0.15  +  0.01  (2) 
pRSV: :Ksp trypsinogen  Trypsinogen  0.15  (1) 
pRSV: :TG  Truncated G  0.005  (1)§ 
B.  Trypsinogen and mutant trypsinogens 
pRSV::trypsinogen  Trypsinogen  0.15  +  0.01  (2) 
pRSV:: Apro trypsin  Apro trypsinll  0.15  (1) 
pRSV:: Apro D--'N trypsin  Apro D~N  trypsin  0.17  (1) 
* Calculated  as in Moore and Kelly (52);  see also Materials  and Methods. 
* Values given +  range where more than one experiment was performed. Numbers in parentheses indicate the number of independent experiments. 
§ Data from Moore and Kelly  (52). 
II See Fig. 5 and text for NHz-terminal  sequence analysis. 
Burgess et al.  Role of Amino  Terminus in Secretory  Protein  Targeting  661 Figure 1. Immunocytochemical  colocalization  of  mouse ACTH (20-nm gold), and rat anionic trypsinogen (5-nm gold) in transformed  AtT-20 
cells. This micrograph shows a large number of dense-core secretory granules which contain both ACTH and trypsinogen. Bar, 200 nm. 
moter (Table I A). This suggests that although these cells ex- 
press higher levels of trypsinogen, the amount is apparently 
not sufficient to observe any saturation of targeting to the 
regulated secretory pathway. The sorting indices oftrypsino- 
gen and the endogenous hormone POMC/ACTH are very 
similar, although both are sorted less efficiently than heter- 
ologously expressed human growth hormone (52). 
The  RSV-'fi'yp cell  line  was  then used  to  perform  the 
double-label immunoelectron microscopy experiment shown 
in Fig.  1. A Lowicryl-embedded section of RSV-Tryp cells 
was stained with rabbit anti-ACI'H antibodies and 20-nm 
gold coupled to goat anti-rabbit second antibody on one side 
of the section, and with rabbit anti-trypsinogen antibodies 
and 5-nm gold coupled to goat anti-rabbit second antibody 
on the other side of the section (see Materials and Methods 
for details). This section shows a large number of  dense-core 
secretory granules that stain for both antigens. We did note 
that in other sections some granules stained for only one anti- 
gen or the other.  This may be an artifact of the two-sided 
technique used in that both antigens were not always equally 
accessible from both sides of the section (see Discussion). 
We conclude that within the limits of our observations the 
exocrine protein trypsinogen is targeted to the same popula- 
tion  of dense  core  secretory granules as  the endogenous 
POMC/ACTH. 
The 1h/psinogen  Signal Peptide Does Not Contain the 
Secretory Granule Targeting Information 
Having thus demonstrated that trypsinogen is  targeted to 
regulated secretory granules, we have begun to dissect the 
trypsinogen molecule to identify domains in the protein that 
specify granule localization. To determine whether the sig- 
nal peptide has any role in protein targeting to the regulated 
pathway,  the trypsinogen signal peptide was replaced with 
the signal peptide from a constitutively secreted protein, the 
kappa MPC 11 immunoglobulin light chain (Matsuuchi and 
Kelly, manuscript submitted for publication). The DNA con- 
struct and the corresponding predicted protein sequence are 
shown in Fig.  2  A.  The trypsinogen signal peptide is  15 
amino acids in length. Signal peptidase cleaves pretrypsino- 
gen after Ala (-1)  2 and before Phe (+1) to produce tryp- 
sinogen. The kappa signal peptide (Ksp) is 28 amino acids 
long (43)  and ends with Gly (-1).  The fusion between the 
Ksp and trypsinogen was made by taking advantage of con- 
venient restriction endonuclease cleavage sites and using a 
Hind III linker to join the Ksp to the trypsinogen sequences 
(see Materials and Methods for details). The resultant DNA 
2. The amino acid numbering system used here is as follows: Signal peptide 
residues are assigned negative numbers beginning with -1, just before the 
cleavage site. The mature sequences are given positive numbers using the 
chymotrypsinogen system of Hartley (35). 
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construction  and  Ksp  trypsinogen 
secretion analysis. (A) The Ksp tryp- 
sinogen expression vector was con- 
structed as described in the text. Re- 
striction endonuclease sites: B, Barn 
HI; H,  Hind HI; and S,  Sst I. The 
solid bar indicates the RSV LTR seg- 
ment used to control Ksp  trypsinogen 
expression. The predicted protein se- 
quences of  the wild-type trypsinogen 
(wt-T)  and Ksp trypsinogen (Ksp-T) 
are given using the one letter amino 
acid code.  A,  alanine;  E,  glutamic 
acid;  F,  phenylalanine;  G,  glycine; 
H, histidine; I, isoleucine; K, lysine; 
L, leucine; M, methionine; Q, gluta- 
mine; S, serine; T, threonine; V, va- 
line;  and  W,  tryptophan.  The  two 
altered amino acids in the Ksp-T se- 
quence, Q and A, are shown in bold lettering. (B) Secretion analysis of wt-T and Ksp-T from transformed AtT-20 ceils. Cells were labeled 
with [3sS]Cys, and then chased for three consecutive 3-h periods. During the third chase, 5 mM 8-Br-eAMP was added to one of two iden- 
tical dishes. Shown are SDS-PAGE gels of anti-trypsinogen-immunoprecipitated media samples from the third chase, either in the absence 
(-) or presence (+) of the secretagogue, 8-Br-cAMP. 
encodes a  signal peptide that is the same length as the Ksp, 
however, the last two amino acids encoded are Gin and Ala, 
instead of Asp and Gly (see Fig.  2  A).  We have not deter- 
mined  whether  these changes  affect the accuracy of signal 
peptidase cleavage.  The RSV LTR was used to control the 
synthesis of the Ksp trypsinogen-fusion protein. AtT-20 cells 
were co-~  with pRSV: :Ksp trypsinogen and pSV'2neo, 
stable cell lines  were selected,  and trypsinogen-expressing 
clones were identified. Several cell lines that synthesized and 
secreted an immunoreactive trypsinogen of the expected mo- 
lecular weight (30,000) were obtained; one of these was fur- 
ther  characterized. 
Figure 3.  pRSV::Apm trypsin construction and Apro trypsin secretion analysis. (A) The Apro trypsin expression vector was constructed 
as described in the text. Restriction endonuclease sites and RSV LTR as in Fig. 2. (X) indicates the location of the eight-amino acid "pro" 
deletion. The approximate location of Asp 102 is also indicated. The predicted protein sequences of wild-type trypsinogen (wt-T) and Apro 
trypsin (Apro-T) are shown in the one-letter amino acid code as in Fig. 2; in addition, D, aspartic acid; N, asparagine; and R, arginine. 
The "pro" deletion is indicated on the wt-T sequence by dashed lines, and the arrow shows the normal signal peptidase cleavage site.  (B) 
Secretion analysis of wt-T, Apro-T, and D--'N Apro trypsin (D-*N Apro-T). Cells were labeled and chased as in Fig. 2. Shown are SDS- 
PAGE gels of anti-trypsinogen-immunoprecipitated media samples from the third chase, in the absence (-) or presence (+) of the secreta- 
gogue 8-Br-cAMP. 
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pressing AtT-20 cell lines. Lane 1, purified rat anionic trypsinogen 
(20 ng) (T' gen Std). Lane 2, trypsinogen (T' gen). Lane 3, en- 
teropeptidase digested trypsinogen (Trypsin). Lane 4, Apro trypsin 
(Apro-T). Lane 5, D~N Apro trypsin (D~N). Lane 6, untrans- 
fected AtT-20 cells (Control). Samples in lanes 2-6 are from the 
appropriate AtT-20  cells. The blot was probed with a specific rabbit 
anti-rat anionic  trypsinogen serum,  followed by an  L25I-labeled 
goat anti-rabbit antibody. Trypsinogen and trypsin migrate with ap- 
parent molecular weights of ----30,000 and ~29,000, respectively. 
The Ksp was cleaved from pretrypsinogen, as judged by 
comparing wild-type trypsinogen and Ksp trypsinogen by 
immunoprecipitation and SDS-PAGE (Fig. 2 B). The secre- 
tion properties of  Ksp trypsinogen were determined using the 
quantitative secretion protocol described previously (52, see 
also Materials and Methods). The secretagogue 8-Br-cAMP 
stimulated the release of Ksp trypsinogen (Fig. 2 B) and the 
sorting index calculated from these secretion data did not dif- 
fer from wild-type trypsinogen (Table I A). For comparison, 
the data for a transfected, constitutively secreted protein, the 
TG protein of vesicular stomatitis virus, is included in Table 
I A (52). There is at least a 30-fold difference in the sorting 
of TG and  the  regulated secretory proteins.  We conclude 
from this experiment that the sorting domain required for 
granule localization in AtT-20 cells is not present in the sig- 
nal peptide of trypsinogen. 
Deletion of the NHrTerminal '~ro" Sequence Does 
Not Alter Targeting to Secretory Granules 
Trypsinogen is  secreted from the pancreas as  an inactive 
zymogen. The protease is converted to trypsin when entero- 
peptidase  (50)  cleaves  off the  NH2-terminal  eight-amino 
acid "pro" sequence. This cleavage triggers a local conforma- 
tional change, whereby the NH2-terminal Ile (+16) of tryp- 
sin forms a critical salt bridge with Asp (+194), a residue 
near  the  active  site  (22,  23,  39,  45,  65).  To  determine 
whether the NH2-terminal "pro" sequence is also involved 
in secretory granule targeting, oligonucleotide-directed mu- 
tagenesis was used to precisely delete the "pro" sequence of 
pretrypsinogen. The DNA construct, (pRSV: :Apro trypsin), 
and predicted protein sequence are shown in Fig. 3 A. (De- 
tails of the mutagenesis are in Materials and Methods.) This 
construction will direct the  synthesis  of a  protein,  which 
upon correct signal peptidase cleavage and proper protein 
folding is an active protease.  Because this active protease 
may be detrimental to the cell, a  second construct that in- 
troduces an active site mutation as well as the "pro" deletion 
was also made (pRSV:: Apro D~N trypsin). The chosen mu- 
tation, Asp--'Asn  102 (D~N  102) has recently been shown 
to reduce the enzymatic activity at least four orders of  magni- 
tude at neutral pH (16). 
Both pRSV:: Apro trypsin and pRSV: :Apro D--'N trypsin 
were used to transfect AtT-20 cells, and clones expressing an 
immunoreactive Apro trypsin were identified by a western 
blot assay.  Fig. 4 shows a Western blot of proteins from the 
various  expressing  cell  lines.  The  anti-trypsinogen  im- 
munoreactive protein from RSV-Tryp cells comigrates with 
a  rat  anionic  trypsinogen standard  (lanes  1  and  2).  En- 
teropeptidase digestion (50) of RSV-Tryp protein yields ma- 
ture trypsin (lane 3). In lanes 4 and 5, the anti-trypsinogen 
immunoreactive proteins from the Apro trypsin and Apro 
D~N trypsin cell lines are shown to comigrate with mature 
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Figure 5.  NH2-terminal protein  sequence 
analysis of Apro trypsin. Both secreted (e) 
and  cell-associated  (a)  [35S]Cys labeled 
Apro  trypsin  samples were  subjected  to 
automated sequence analysis. Anilinothia- 
zolinone amino acids were collected at each 
cycle and 35S counts per minute were deter- 
mined.  The  protein  sequence  of mature 
trypsin  is  shown on top in the one letter 
amino acid code as in Figs. 2 and 3; in addi- 
tion, C, cysteine, and Y, tyrosine. The de- 
duced sequence of Apro trypsin is shown on 
the bottom line. The C's are shown in bold 
lettering to emphasize that  these  are  the 
only amino acids directly identified using 
this method. 
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trypsin did not seem to affect the cells in any way (see below) 
and the efficiency of transfection was not detectably altered. 
When the Apro trypsin- and Apro D--'N trypsin-express- 
ing cell lines were exposed to secretagogues, the rate of Apro 
trypsin secretion was stimulated (Fig. 3 B). The sorting in- 
dex calculated for both of these mutant trypsin proteins did 
not differ from wild-type trypsinogen (Table I B). We con- 
clude that the granule targeting information is not present in 
the NHz-terminal "pro" sequence of trypsinogen. 
A pro Trypsin Is Not Enzymatically Active 
Cells expressing Apro trypsin were viable and unexpectedly 
indistinguishable  from cells expressing trypsinogen or the 
active site mutant Apro D~N trypsin. Using a variety of as- 
says including binding to bovine pancreatic trypsin inhibitor, 
hydrolysis of highly sensitive fluorescent peptide substrates 
(15), and a gel overlay activity assay (Evnin,  L., and C. S. 
Craik, unpublished results), we were unable to demonstrate 
any trypsin activity from Apro trypsin-expressing  cells. In 
contrast, the media from trypsinogen expressing cells when 
digested with enteropeptidase always showed trypsin activity 
(data not shown).  The inactivity could be due to incorrect 
folding of Apro trypsin. This possibility seems unlikely be- 
cause this protein is efficiently synthesized, transported, and 
secreted from AtT-20 cells. Another possible explanation is 
that the signal peptidase does not cleave in the expected loca- 
tion.  If the NH2-terminal  Ile (+16)  of trypsin is modified 
(57, 60), all proteolytic activity is lost. The structural (22, 
39, 45, 65) and binding (6, 7) data further suggest that there 
is a specific binding pocket for the NH2 terminus, such that 
incorrect cleavage would not allow the active conformation 
to be achieved. 
To determine the NH2-terminal amino acid of Apro tryp- 
sin,  automated  NH2-terminal  radiosequence  analysis  was 
performed  on  a  [35S]Cys-labeled immunoprecipitated  and 
gel-purified Apro trypsin sample. If the NH2 terminus is Ile 
(+16) as expected,  [35S]Cys counts should be found in cy- 
cles 7 and 25 (see Fig. 5). If, however, we find peaks of 35S 
counts at other positions,  but separated by the same num- 
ber  of cycles,  the  altered  NH2-terminal  sequence  can  be 
deduced. 
Our sequence analysis of Apro trypsin shows peaks of ra- 
dioactivity in cycles 3 and 21 (Fig. 5). These data along with 
the SDS-PAGE size analysis showing that Apro trypsin is the 
expected molecular weight, are consistent with the NH2 ter- 
minus being at Tyr (+20), four amino acids shorter than ex- 
pected. Analyses performed on both media and cell extract 
samples gave similar results, ruling out the possibility of ex- 
tracellular  proteolysis.  This  result,  which places the  NH2 
terminus at Tyr (+20), is fully consistent with our inability 
to demonstrate any Apro trypsin activity. We conclude that 
Apro  trypsin  is  not  active  because  it  is  proteolytically 
cleaved (probably by signal peptidase) between Gly (+19) 
and Tyr (+20) instead of between Ala (-1) and lie (+16) as 
expected. Furthermore,  because the Apro trypsin protein is 
actually missing the first 12 amino acids of trypsinogen (not 
just the 8-residue "pro" sequence), we can also conclude that 
the  first  12-NH2-terminal  amino  acids  of trypsinogen  are 
not essential for targeting to the regulated secretory pathway. 
Discussion 
In this article, we show that the exocrine protein trypsinogen 
is targeted into the same dense-core secretory granule as the 
endogenous endocrine protein POMC/ACTH in the anterior 
pituitary tumor cell line, AtT-20.  To identify the protein do- 
main responsible for this intracellular  sorting process,  we 
have begun to express mutant trypsinogen proteins to try to 
alter intracellular targeting.  Many other intracellular target- 
ing signals are located at the NH2 terminus of the targeted 
protein. For example, in procarboxypeptidase Y, the vacuo- 
lar targeting signal resides in the NH2-terminal propeptide 
(42, 69). In contrast, neither the extreme NH2-terminal sig- 
nal sequence of pretrypsinogen nor the NH2-terminal "pro" 
domain of trypsinogen are required for targeting to the regu- 
lated secretory pathway in AtT-20 cells. 
POMC/ACTH and trypsinogen were colocalized in dense- 
core secretory granules using a double immunocytochemi- 
cal-staining  procedure with antibodies specific for POMC/ 
ACTH and  trypsinogen.  This  technique  involves reacting 
each primary antibody with only one side of a section, and 
using different-sized gold particles, coupled to secondary an- 
tibodies,  to  detect  each  antigen  separately.  Although  we 
found granules that stained for only a single antigen when 
using  this  two-sided technique,  we do  not believe this  is 
significant. Control experiments in which the same primary 
antibody was used on both sides of the grid,  indicated that 
all granules were not equally accessible from both sides of 
the section (see discussion in Bendayan [3]). This seems rea- 
sonable since the sections are of nearly the same thickness 
(800  ~,)  as the  diameter  of individual  secretory granules 
(diam  =  1,000/~),  and therefore many granules should be 
accessible from only one side of the section. 
Recently, Fumagalli  and Zanini  (24) showed that mixed 
somatomammotrophic cells of cow pituitary (which express 
both growth hormone and prolactin), can package their hor- 
mones  into  separate  secretory granules  as  well as  mixed 
within the same granule. Interestingly, they also found some 
granules in which the hormones were segregated into distinct 
domains within the secretory granules.  They suggested that 
mechanisms  exist  within  somatomammotrophic  cells  for 
sorting  growth hormone  and prolactin  into  separate gran- 
ules. Bassetti et al. (1) have presented morphologic evidence 
for mixed packaging of growth hormone and prolactin into 
the secretory granules of human pituitary tumors. They also 
noted that in one tumor they saw separate growth hormone 
containing granules as well as mixed granules.  In contrast, 
we have no compelling evidence that AtT-20 cells have the 
ability to distinguish  between different regulated secretory 
proteins;  POMC/ACTH and trypsinogen appear to be tar- 
geted to secretory granules indistinguishable by both the bio- 
chemical  (8) and morphologic criteria. 
Our finding that replacing the trypsinogen signal peptide 
with the signal peptide from a constitutive protein does not 
alter  targeting  to  secretory granules  was not unexpected. 
NH2-terminal  signal peptides are known to be responsible 
for signal recognition particle dependent ER targeting  (for 
review,  see  Walter  et  al.  [73]).  Once  the  nascent  poly- 
peptide is inserted into the ER membrane,  signal peptidase 
makes a specific cleavage that removes the signal peptide (21, 
41, 51), probably co-translationally (4, 27). The signal pep- 
tide could only be involved in granule targeting if the initial 
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sorting apparatus takes place in the ER. Protein sorting into 
the regulated secretory pathway is thought to be a post-Golgi 
apparatus event (44), and the data presented here are consis- 
tent with this view. 
In designing our trypsinogen mutation strategy, we have 
relied on the structural  data available for both trypsinogen 
(22, 45) and trypsin (39, 65). Inasmuch as the conversion of 
trypsinogen to trypsin involves predominantly  local struc- 
tural changes, we reasoned that deleting the "pro" sequence 
would l~rmrb the protein structure to such a small extent that 
the mutant protein would still be transported beyond the ER 
to the cell surface. Similarly, although the active site muta- 
tion reduces the proteolytic activity at least four orders of 
magnitude at neutral pH (16), the three-dimensional  struc- 
ture of the D---N102  mutant protein is virtually identical to 
the  wild-type  protein  (64).  The  kinetics  of intracellular 
transport of both the Apro and Apro D--'N variants were 
slowed about twofold compared with trypsinogen (data not 
shown); however, the efficiency of sorting into the regulated 
secretory pathway was not altered (Table I B). Although the 
NH2-terminal "pro" domain of trypsinogen does not appear 
to be required for protein targeting to the regulated secretion 
pathway in ART-20 cells, the possibility remains that the tar- 
geting information is redundant.  Either the "pro" sequence 
or another sequence may be sufficient for protein targeting 
to the regulated secretion pathway. 
Our  ability  to  recover  Apro  trypsin  expressing  AtT-20 
clones was surprising as we expected pRSV:: Apro trypsin to 
direct the synthesis of the potent protease,  trypsin.  Direct 
protease activity measurements indicated that Apro trypsin 
was not enzymatically active. NH2-terminal sequence anal- 
ysis  of  [35S]Cys-labeled,  immunopurified  Apro  trypsin 
(Fig. 5) indicated that the first four amino acids of wild-type 
trypsin were missing from Apro trypsin purified from either 
radiolabeled cell extracts or media samples.  The NH2-ter- 
minal Ile (+16) is required for enzymatic activity (57, 60), 
and thus this result explains why Apro trypsin is not active. 
However, it is unclear why this unexpected NH2-terminus is 
created. 
Using a recently published method for predicting  signal 
sequence cleavage sites (71), we calculated weighted scores 
along the wild-type pretrypsinogen and preApro trypsin se- 
quences. Whereas this calculation method correctly predicts 
the wild-type pretrypsinogen signal peptide cleavage site be- 
tween Ala (-1) and Phe (+1), it does not predict the observed 
cleavage site in preApro trypsin between Gly (+19) and Tyr 
(+20).  Although the score at this position is only the sixth 
highest along the preApro trypsin sequence, it does occur as 
a local peak. The weighted calculation method used here re- 
lies largely on the sequence of the signal peptide itself; in that 
this sequence is unchanged in Apro trypsin, the specificity 
of the proteolytic cleavage must be affected by the sequences 
COOH-terminal  to  the  signal  sequence.  The  prediction 
method, however, does not rely on the overall length of the 
signal peptide. The observed cleavage site of preApro tryp- 
sin increases the signal peptide length from 15 to 19 residues 
which may play a role in cleavage site selection. 
The data presented here suggest that the secretory granule 
targeting  information  of trypsinogen  is not present  at the 
NH2 terminus of the protein,  thus the information must be 
contained within the mature portion of the protein. We have 
previously compared the primary structures of many differ- 
ent regulated secretory proteins in search of some common 
targeting  sequence;  none  was found.  We suggest that  the 
secretory granule targeting signal might  be similar to signal 
peptides, showing no primary sequence homology, yet dis- 
playing functional identity with one another.  The common 
targeting information may interact with a presumptive sort- 
ing receptor via a primary sequence-independent association 
similar to that recently described for peptide antigens with 
the class II major histocompatibility antigen (30). 
The conventional approach to identify a protein domain 
containing  targeting  information  is to generate fusion pro- 
teins  where the presumptive  sorting domain is fused to a 
reporter  element.  To study sorting  in the Golgi complex, 
however, such fusion proteins must first escape the ER. Re- 
cent experiments from this laboratory (Matsuuchi and Kelly, 
manuscript  submitted  for  publication;  53)  have  demon- 
strated that this may be a major limitation. The mutation ap- 
proach described here offers an alternative strategy. If a mu- 
tation causes loss of targeting,  it could be due to removal of 
a targeting signal, or aberrant protein folding that could ob- 
scure a targeting  signal.  If, however, targeting can be dis- 
rupted without loss of enzymatic activity, one can make the 
reasonable argument that the protein structure is intact, and 
the  targeting  signal  itself has  been altered  (58,  69).  The 
knowledge of the three-dimensional structure of trypsinogen 
may facilitate the design of such catalytically active but in- 
correctly targeted proteins. 
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